News

TEL：+86-21-33585366（DDT）
     34666753、33588661
FAX：+86-21-34979012
Q Q：  2762556331（Domestic）
      3501899018（Export）
E-mail：info@shyrchem.com
Domestic：sales@shyrchem.com
Export：sales02@shyrchem.com

Your current location：Home > News

The performance of various sub tracks in the pharmaceutical sector was prosperous in the third quart 2024-10-15
In the field of depression drugs, many domestic pharmaceutical companies are focusing on the researc 2024-10-11
Mergers and acquisitions in the pharmaceutical industry are coming one after another 2024-10-09
The development prospects of cell therapy drugs are promising 2024-09-29
The domestic stem cell innovative drug industry is being catalyzed 2024-09-26
Multiple pharmaceutical companies disclose progress in clinical trials of innovative drugs 2024-09-23
21 super rolling 1 billion varieties 2024-09-19
The number of innovative drugs approved for market in China has increased by nearly 20% year-on-year 2024-09-13
The pharmaceutical sector is expected to return as the king! 2024-09-10
Chinese innovative pharmaceutical companies' overseas transactions will continue to emerge 2024-09-05

Pages：2/8 page10 total71 home last next end go to:

Copyright © 2017-2020 SHANGHAI YINGRUI BIOPHARMA CO.,LTD 沪ICP备11038445号-1
TEL：+86-21-33585366(DDT)、34666753 FAX：+86-21-34979012
E-mail：info@shyrchem.com ADD：1885 Metropolitan Road, Minhang District, Shanghai Code：201108